AP3414A
(en )
2015-09-30
Compositions and methods for modulating fxr
HK1246715A1
(en )
2018-09-14
Compositions and methods for targeted thermomodulation
IL226196A0
(en )
2013-07-31
Methods and compositions for modulating pd1
EP2569429A4
(en )
2013-09-25
Compositions and methods for modulating metabolism
AP2014008100A0
(en )
2014-12-31
Compositions and methods for modulating hemoglobingene family expression
SG2014010706A
(en )
2014-05-29
Method and composition
GB201016001D0
(en )
2010-11-10
Composition and method
PL2624702T3
(en )
2016-09-30
Anti-biofilm compositions and methods for using
EP2629742A4
(en )
2015-12-16
Hair-mending compositions and associated methods
EP2575825A4
(en )
2014-01-01
Compositions and methods for treating depression
IL225391A0
(en )
2013-06-27
Methods and compositions for modulating the wnt pathway
EP2760887A4
(en )
2015-06-10
Compositions and methods for modulating hemostasis
GB201003531D0
(en )
2010-04-21
Composition and method
HK1201451A1
(en )
2015-09-04
Compositions and methods
EP2611902A4
(en )
2014-03-26
Compositions and methods for modulating emt and uses thereof
GB201018650D0
(en )
2010-12-22
Methods and compositions
GB201008843D0
(en )
2010-07-14
Method and composition
GB201008364D0
(en )
2010-07-07
Composition and method
GB2478399B
(en )
2014-12-17
Toner compositions and methods
HK1174624A1
(en )
2013-06-14
Cyclopentyl- and cycloheptylpyrazoles as fxr modulators fxr -
ME02797B
(en )
2018-01-20
Compositions and methods for modulating fxr
IL220796A0
(en )
2012-08-30
Compositions and methods for treating gliblastoma gbm
GB201018651D0
(en )
2010-12-22
Methods and compositions
GB201010083D0
(en )
2010-07-21
Compositions and methods
GB201009767D0
(en )
2010-07-21
Compositions and methods